Key Highlights

  • CareCloud signed several new wound care clients during the fourth quarter.
  • Its bi-directional EHR interface lets practices use its services without replacing their existing system.
  • Its Empower division supported appeals of about $3 million in alleged Medicare overpayments.
  • Vantage Health Collective selected CareCloud as a preferred vendor.

CareCloud, Inc. (NASDAQ:CCLD) is expanding its presence in wound care, a specialty where it provides AI-enabled healthcare technology and Revenue cycle management services. The company has reported new fourth-quarter clients, a software integration and payer audit results tied to its Empower Healthcare & Compliance division. The update, published on November 11, 2026, places the company's specialty work within a reimbursement environment that is becoming more complex. Wound care is a large and growing area of medical treatment, and providers in the field face complex billing and documentation rules. Revenue cycle management companies work to manage those processes, which makes reimbursement policy a central Factor for firms that serve the sector.

New Clients and a Preferred Vendor Designation

CareCloud signed multiple wound care clients during the fourth quarter and was selected as a preferred vendor by Vantage Health Collective, a multi-specialty management services organization. The initial engagement covers three practices in Texas, northern Florida and California.

The company also launched a bi-directional EHR interface, which allows wound care practices to adopt its revenue cycle and compliance services without replacing their existing electronic health record system. A mobile wound care practice became the first to go live on the integration, through a relationship developed with Kindling Consulting.

A bi-directional interface exchanges information in both directions between systems, so a practice can keep its existing record system while sending and receiving billing and compliance data. That design removes the need for a full system change, which the company presents as a barrier that is now lower for prospective clients.

Payer Audit Results at Empower

Empower supported a wound care provider, represented by the law firm Frier Levitt, in a successful appeal of approximately $3 million in alleged Medicare overpayments related to skin substitute grafts. The company said the case follows an earlier matter in which another wound care provider overturned more than $1 million in alleged overpayments after an administrative law judge appeal.

The results rely on Empower's coding, documentation and compliance work, which CareCloud presents as a differentiator for wound care providers. Each outcome is specific to a case, so the results cannot be extended to all payer disputes.

Medicare overpayment disputes often involve detailed reviews of coding and documentation, and the appeals process can take considerable time. The company's compliance division is described as specialized in those areas, which is why it is presented as a distinct service alongside revenue cycle work.

Market Size and Reimbursement Pressure

The company cited a 2023 study in the Journal of Medical Economics that estimated Medicare wound care spending at $22.5 billion in 2019. It also referenced projections from the National Association of ACOs that Medicare skin substitute spending would reach $15.4 billion in 2025.

Those figures point to a sizable market, although they come from different sources and years. They do not show how much of that spending could flow to CareCloud's services.

Skin substitute products have become a major area of Medicare spending, and reimbursement rules for them have been subject to change. The projections cited in the update come from outside organizations and show how the category has expanded in recent years.

Operating Model and Client Base

CareCloud describes itself as a provider of AI-powered healthcare technology and revenue cycle services. The wound care work sits within that broader model, with new clients coming in through partnerships, integrations and referrals from management groups.

The mix of services, from billing to audit defense, means that growth can come from several channels at once. The update does not state how many clients are now served in the specialty or how much of the company's revenue it represents.

Final Word

CareCloud's wound care activity combines new clients, a technology integration and compliance support that depends on appeals and audits. The payer results are case-specific, and the revenue from the segment is not quantified in the update. Future quarterly figures will show whether the new clients and the EHR interface translate into a larger share of the wound care services market. The payer and integration developments are meaningful for the company's positioning, although their financial scale is not disclosed.